Skip to main navigation Skip to search Skip to main content

Continuation Trial of Beliumab, a Fully Human Monoclonal Anti-BLyS Antibody in Subjects with SLE who Completed Phase 3 Protocol HGS1006C-1056

    Project: Research

    Project Details

    StatusActive
    Effective start/end date07/9/08 → …